miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 2, 2012, Pages 177-182

  Zhao, Huijie ^a   Zhu, Lei ^a   Jin, Yujuan ^a   Ji, Hongbin ^a   Yan, Xiumin ^a   Zhu, Xueliang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

ASCL1; miR 375; small cell lung cancer

Indexed keywords

ASCL1 PROTEIN, HUMAN; ASCL1 PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MICRORNA; MIRN375 MICRORNA, HUMAN; MIRN375 MICRORNA, MOUSE; PRIMER DNA;

ANIMAL; ARTICLE; BINDING SITE; E BOX ELEMENT; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SMALL CELL CARCINOMA; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DNA PRIMERS; E-BOX ELEMENTS; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84863075009     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr110     Document Type: Article

References (31)

1. Dowell JE. Small cell lung cancer: Are we making progress? Am J Med Sci 2010, 339: 68-76.
2. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A and Spitznagel EL, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24: 4539-4544.
3. Senden NH, Timmer ED, de Bruine A, Wagenaar SS, Van de Velde HJ, Roebroek AJ and Van de Ven WJ, et al. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. J Pathol 1997, 182: 13-21.
4. Carey FA and Save VE. Neuroendocrine differentiation in lung cancer. J Pathol 1997, 182: 9-10.
5. Graff L, Castrop F, Bauer M, Hofler H and Gratzl M. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: A signature of human small cell lung carcinoma. Cancer Res 2001, 61: 2138-2144.
6. Ball DW. Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett 2004, 204: 159-169.
7. Hirsch MR, Tiveron MC, Guillemot F, Brunet JF and Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 1998, 125: 599-608.
8. Jiang T, Collins BJ, Jin N, Watkins DN, Brock MV, Matsui W and Nelkin BD, et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 2009, 69: 845-854.
9. Linnoila RI, Zhao B, DeMayo JL, Nelkin BD, Baylin SB, DeMayo FJ and Ball DW. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res 2000, 60: 4005-4009.
10. Blenkiron C and Miska EA. miRNAs in cancer: Approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007, 16(Spec No 1): R106-113.
11. Shi Y, Zhao X, Hsieh J, Wichterle H, Impey S, Banerjee S and Neveu P, et al. MicroRNA regulation of neural stem cells and neurogenesis. J Neurosci 2010, 30: 14931-14936.
12. Chen LH, Chiou GY, Chen YW, Li HY and Chiou SH. microRNA and aging: A novel modulator in regulating the aging network. Ageing Res Rev 2010, 9(Suppl 1): S59-S66.
13. Williams AH, Liu N, van Rooij E and Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009, 21: 461-469.
14. Shenouda SK and Alahari SK. MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Rev 2009, 28: 369-378.
15. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10: 704-714.
16. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435: 839-843.
17. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133: 217-222.
18. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C and Jensen K, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132: 860-874.
19. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ and Newman J, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132: 875-886.
20. He XY, Chen JX, Zhang Z, Li CL, Peng QL and Peng HM. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol 2010, 136: 1023-1028.
21. Osada H and Takahashi T. let-7 and miR-17-92: Small-sized major players in lung cancer development. Cancer Sci 2011, 102: 9-17.
22. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT and Barbisin M, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33: E179.
23. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ and Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003, 4: 181-189.
24. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E and Walker MD. The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 2009, 4: E5033.
25. Nishikawa E, Osada H, Okazaki Y, Arima C, Tomida S, Tatematsu Y and Taguchi A, et al. MiR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 2011, 71: 6165-6173.
26. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R and Malekpour F, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010, 70: 9175-9184.
27. Szczyrba J, Nolte E, Wach S, Kremmer E, Stohr R, Hartmann A and Wieland W, et al. Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma. Mol Cancer Res 2011, 9: 791-800.
28. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T and Hijiya N, et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010, 70: 2339-2349.
29. Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y and Yao H, et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010, 20: 784-793.
30. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL and Peterson A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105: 10513-10518.
31. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K and Guo J, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18: 997-1006.